DNA News and Research

RSS

DNA, or deoxyribonucleic acid, is the hereditary material in humans and almost all other organisms. Nearly every cell in a person’s body has the same DNA. Most DNA is located in the cell nucleus (where it is called nuclear DNA), but a small amount of DNA can also be found in the mitochondria (where it is called mitochondrial DNA or mtDNA).

Researchers reveal that genes contributing to drug resistance in NSCLC disease could be predicted

The genes that may contribute to drug resistance in non-small cell lung cancer (NSCLC) can be predicted. Researchers writing in the open access journal BMC Cancer found good correlation between genes believed to be involved in drug sensitivity and resistance and actual in vitro chemosensitivity.

26 Aug 2009

Cardium announced that patients enrolled for MATRIX clinical trail have completed their evaluation period

Cardium Therapeutics (NYSE Amex: CXM) today announced that all patients enrolled in the Company's MATRIX clinical study have now completed their initial 12-week evaluation period and that it plans to provide detailed safety and efficacy data in late September 2009.

26 Aug 2009

Profectus BioSciences to conduct proof-of-concept studies with its rVSV vector technology

Profectus BioSciences, Inc. (Profectus), a clinical stage biopharmaceutical company focused on the development of novel vaccine candidates for serious chronic infections, announced today it has entered into a research collaboration agreement with the PATH Malaria Vaccine Initiative (MVI) to conduct proof-of-concept studies with its proprietary, recombinant vesicular stomatitis virus (rVSV) vector technology as a preventative malaria vaccine.

26 Aug 2009

University of Idaho researchers to develop a chemical probe technology that can treat genetic diseases

Three University of Idaho researchers will embark on an unconventional approach to DNA research as one of 20 teams chosen nationwide by federal officials for the ideas to explore scientific frontiers.

26 Aug 2009

NCI investigator’s endorsement of of inaccurate high-risk HPV test to refer women to cervical cancer tests is “unfortunate and inappropriate” says Sin Hang Lee

A National Cancer Institute (NCI) investigator’s endorsement of inaccurate high-risk HPV test to refer women to cervical cancer tests, despite the weak evidence of its value, is “unfortunate and inappropriate.”

25 Aug 2009

Cytrx’s study offers a better perception of arimoclomol's mechanism of action in induced animal stroke

CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, today announced that study results demonstrated that arimoclomol exhibited both statistically significant neuroprotective and neuroregenerative effects in brain cells of animals induced with stroke, offering important insights into this drug candidate’s mechanism of action.

25 Aug 2009

Illumina's new stock repurchase program effective in returning value to shareholders

Illumina, Inc. today announced that its Board of Directors has approved a new stock repurchase program, authorizing the Company to repurchase in the aggregate up to $75 million of its outstanding common stock.

From Illumina, Inc. 25 Aug 2009

Field and DNA studies reveal that marine reserves aid in shark conservation measures

A long-term field and DNA study by the Institute for Ocean Conservation Science at Stony Brook University, University of Miami, Field Museum of Chicago and others has shown that young lemon sharks born at the Bimini islands, Bahamas, tend to stay near their coastal birthplace for many years.

25 Aug 2009

Research reveals the life-long detrimental impact of maternal smoking during pregnancy

A new study by researchers at the Keck School of Medicine of the University of Southern California (USC) has found that the life-long effects of maternal smoking during pregnancy may occur through specific changes in DNA patterns.

25 Aug 2009

New technique developed to identify gene copy number variations

A research team led by Associate Professor Jonathan Sebat, Ph.D., of Cold Spring Harbor Laboratory (CSHL) has developed a sensitive and accurate way of identifying gene copy number variations (CNVs).

25 Aug 2009

INSERM researchers engineer a chimeric protein that improves stem cell engraftment

Researchers at INSERM (France) have engineered a chimeric protein that increases cell survival, migration and proliferation to improve stem cell engraftment. The results, which appear in the September 2009 issue of Experimental Biology and Medicine, show that TAT-Tpr-Met, a cell permeable form of the hepatocyte growth factor receptor can increase the number of hepatic stem cells integrated into the liver of the mouse.

24 Aug 2009

Bioniche Life Sciences update on Phase III clinical program for evaluating Urocidin

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today provided an update on its Phase III clinical program evaluating Urocidin(TM) in the treatment of bladder cancer.

24 Aug 2009

Complete Genomics raises $45 million in private equity financing

Complete Genomics Inc., a third-generation human genome sequencing company, announced that it has raised $45 million in private equity financing and closed its Series D funding round with two new investors — Essex Woodlands Health Ventures and OrbiMed Advisors, LLC.

24 Aug 2009

Researchers identify causative gene for features of 2q32q33 microdeletion syndrome

...

24 Aug 2009

Curemark Founder delivers Industry Keynote address at Epigenomics Conference 2009

Curemark Founder and CEO Dr. Joan Fallon delivered the Industry Keynote address at the Third International Epigenomics, Sequencing 2009 Conference at Harvard Medical School on July 14th

24 Aug 2009

Researchers discover elusive nanoscale movements of ribosomes at work

Researchers at the University of California, Berkeley, have for the first time captured elusive nanoscale movements of ribosomes at work, shedding light on how these cellular factories take in genetic instructions and amino acids to churn out proteins.

24 Aug 2009

New noninvasive technique to detect colorectal and gastric cancers found

A preliminary evaluation of methylation of two gene promoters in fecal DNA showed promise as a noninvasive method to detect colorectal and gastric cancers, according to a new study published online August 21 in the Journal of the National Cancer Institute.

24 Aug 2009

Discovery of mutation in AIP gene associated with acromegaly

An indigenous family living in a mountainous area of Malaysian Borneo helped Van Andel Research Institute (VARI) researchers to discover information about genetic mutations associated with acromegaly, a form of gigantism that often results in enlarged hands, feet, and facial features.

24 Aug 2009

Ends of protein templates useful for arresting growth of cancerous cells

The tail ends of cellular protein templates, regions often thought relatively inconsequential, may actually play a role in preventing normal cells from becoming cancerous. The finding from scientists at Whitehead Institute for Biomedical research is reported in the August 20 edition of Cell.

21 Aug 2009

Chinese scientists present study on oxycholesterol's cholesterol-boosting effects at 238th ACS meeting

Health-conscious people know that high levels of total cholesterol and LDL cholesterol (the so-called "bad" cholesterol) can increase the risk of heart attacks. Now scientists are reporting that another form of cholesterol called oxycholesterol - virtually unknown to the public - may be the most serious cardiovascular health threat of all. Scientists from China presented one of the first studies on the cholesterol-boosting effects of oxycholesterol here today at the 238th National Meeting of the American Chemical Society. The researchers hope their findings raise public awareness about oxycholesterol, including foods with the highest levels of the substance and other foods that can combat oxycholesterol's effects.

21 Aug 2009

DNA News and Research

Further Reading

Researchers reveal that genes contributing to drug resistance in NSCLC disease could be predicted

Cardium announced that patients enrolled for MATRIX clinical trail have completed their evaluation period

Profectus BioSciences to conduct proof-of-concept studies with its rVSV vector technology

University of Idaho researchers to develop a chemical probe technology that can treat genetic diseases

NCI investigator’s endorsement of of inaccurate high-risk HPV test to refer women to cervical cancer tests is “unfortunate and inappropriate” says Sin Hang Lee

Cytrx’s study offers a better perception of arimoclomol's mechanism of action in induced animal stroke

Illumina's new stock repurchase program effective in returning value to shareholders

Field and DNA studies reveal that marine reserves aid in shark conservation measures

Research reveals the life-long detrimental impact of maternal smoking during pregnancy

New technique developed to identify gene copy number variations

INSERM researchers engineer a chimeric protein that improves stem cell engraftment

Bioniche Life Sciences update on Phase III clinical program for evaluating Urocidin

Complete Genomics raises $45 million in private equity financing

Researchers identify causative gene for features of 2q32q33 microdeletion syndrome

Curemark Founder delivers Industry Keynote address at Epigenomics Conference 2009

Researchers discover elusive nanoscale movements of ribosomes at work

New noninvasive technique to detect colorectal and gastric cancers found

Discovery of mutation in AIP gene associated with acromegaly

Ends of protein templates useful for arresting growth of cancerous cells

Chinese scientists present study on oxycholesterol's cholesterol-boosting effects at 238th ACS meeting

Understanding the DNA Damage Response in Innate Immunity eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo